References

1. 1.
   National Center for Cardiovascular Diseases，The Writing Committee of the Report on Cardiovascular Health and Diseases in China.Report on cardiovascular health and diseases in China 2023［J］.Chin Circ J，2024，39（7）：625-660.
2. 2.
   LIU M B，HE X Y，YANG X H，et al.Interpretation of report on cardiovascular health and diseases in China 2023（Prevalence of cardiovascular diseases and interventional diagnosis and treatment）［J］.Chin J Interv Cardiol，2024，32（10）：541-550.
3. 3.
   XIAO Y，LI W，ZHOU J，et al.Impact of depression and/or anxiety on patients with percutaneous coronary interventions after acute coronary syndrome：A protocol for a real-world prospective cohort study［J］.BMJ Open，2019，9（9）：e027964.
4. 4.
   TEO K K，LIU L，CHOW C K，et al.Potentially modifiable risk factors associated with myocardial infarction in China：the INTERHEART China study［J］.Heart，2009，95（22）：1857-1864.
5. 5.
   KIM J M，KIM J W，KANG H J，et al.Identification of depression in patients with acute coronary syndrome using multiple serum biomarkers［J］.Gen Hosp Psychiatry，2024，88：1-9.
6. 6.
   CHENG J X，WANG L N，WANG L.The influence of depression on stent restenosis in patients with acute myocardial infarction after PCI［J］.J Int Psychiatry，2020，47（6）：1204-1206，1209.
7. 7.
   LI J X ，ZHANG F J，LIU X，et al.Mechanism of heart rate variability and research advance in its relevance to cardiovascular diseases［J］.J Electrocardiol，2021，30（4）：293-296.
8. 8.
   KREMPEL L，STRICKER J，MARTIN A.Heart rate variability，autonomic reactivity，and emotion regulation during sadness induction in somatic symptom disorder［J］.Int J Behav Med，2025，32（2）：227-237.
9. 9.
   JØRGENSEN T，DANTOFT T M，PETERSEN M W，et al.Is reduced heart rate variability associated with functional somatic disorders？ A cross-sectional population-based study； Dan Fun D［J］.BMJ Open，2024，14（2）：e073909.
10. 10.
    SANG Y Y，WANG Q，YU P ，et al.Percutaneous coronary artery in patients with acute myocardial infarction based on heart rate variability parameters：Construction and evaluation of predictive model for adverse cardiovascular events in hospital after interventional therapy［J］.Clin J Mil Med，2024，52（8）：850-853.
11. 11.
    LIU C，ZHANG S W，XIE G J.Correlation between abnormal changes of dynamic electrocardiogram and prognosis of coronary heart disease after PCI［J］.West Chin Med J，2023，35（11）：1647-1651，1656.
12. 12.
    DU M，SHEN H，FENG X T，et al.Clinical effect of Tiaoxin formula in treatment of patients with coronary heart disease and anxiety/depression and its impact on serum 5-HT，β-TG and MPO levels［J］Chin J Exp Tradit Med Form，2023，29（5）：150-157.
13. 13.
    Neuropsychology and Behavioral Neurology Group，Society of Neurology，Chinese Medical Association. Expert consensus on diagnosis and treatment of anxiety，depression，and somatization symptoms in general hospitals［J］.Chin J Neurol，2016，49（12）：908-917.
14. 14.
    ZHUANG Q，MAO J L，LI C B.Development and validation of the somatic self-rating scale： A study on its reliability and validity［J］.Chin J Behav Med Brain，2010，19（9）：847-849.
15. 15.
    ZHENG X Y．Guiding principles for clinical research of new Chinese medicine［Ｍ］．Beijing：China Medical Science and Technology Press，2002：68
16. 16.
    JIANG J．Construction of new diagnostic and therapeutic system of depression syndrome［J］.Chin J Tradit Chin Med Pharm，2023，38（1）：18-25.
17. 17.
    XU F，LU H，QI Y.Analysis on somatization symptoms and anxiety and depression status in patients with acute myocardial infarction following emergency percutaneous coronary intervention［J］.Chin Comm Dors，2022，38（3）：34-36.
18. 18.
    LONG S，LIU X D，LI T T，et al.Mechanisms and treatments of post-PCI anxiety and depression of patients with coronary heart disease：A review of literature［J］.J Pract Med，2023，39（21）：2850-2856.
19. 19.
    BLUMENTHAL J A，SMITH P J，JIANG W，et al.Effect of exercise，escitalopram，or placebo on anxiety in patients with coronary heart disease：The understanding the benefits of exercise and escitalopram in anxious patients with coronary heart disease （UNWIND） randomized clinical trial［J］.JAMA Psychiatry，2021，78（11）：1270-1278.
20. 20.
    LIU Q，WANG M X，WANG H Y，et al.Xinkeshu for coronary heart disease complicated with anxiety or depression：A Meta-analysis of randomized controlled trials［J］.J Ethnopharmacol，2023，312：116486.
21. 21.
    CHEN M T，ZHONG G F，MEN L ，et al.Effectiveness and safety of Xinkeshu on coronary artery disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention：A protocol for systematic review and Meta-analysis［J］.Medicine （Baltimore），2021，100（46）：e27912.
22. 22.
    LIU Q，WANG H Y，XIE H T，et al.Efficacy and safety of traditional Chinese medicine in the treatment of coronary heart disease complicated with anxiety and/or depression after PCI：A systematic review and Meta-analysis［J］.J Hainan Med Univ，2022，28（7）：528-538.
23. 23.
    WANG M，LI Y，JIANG J H，et al.Effect of Tianwang Buxin Dan on somatization symptoms，anxiety and depression in patients with myocardial bridge［J］.China's Naturopathy，2021，29（11）：62-66.
24. 24.
    LIU X，LIU J.Observation on curative effect of Tianwang Buxin Dan in treating cardiac neurosis［J］.Mod J Integr Tradit West Med，2000，9（14）：1345.
25. 25.
    GUO H L，XU S L，ZHOU Q.Clinical observation on treatment of premature ventricular contraction due to deficiency of both Qi and Yin with Tianwang Buxin Dan and Guizhi Gancao Longgu Muli decoction［J］.J Tradit Chin Med，2023，42（6）：621-625.
26. 26.
    GUO Y Q，AN D Q.The principle of ointment prescription for treating heart diseases［J］.Chin J Integr Med Cardio-Cerebrovasc Dis，2024，22（12）：2124-2130.
27. 27.
    HUANG L S，LIAO W L，LUO Q L.Effect of Chinese medicinal ointment Yiqi Huoxue ointment combined with metoprolol on the therapeutic effect，SDNN and RMSSD levels in patients with unstable angina pectoris of coronary heart disease［J］. Inner Mongolia J Chin Med，2023，42（6）：6-7.
28. 28.
    LIANG X F，XU B，HE G P.Clinical observation on the somatization disorder in patients with cardiology department treated with Delixin［J］.J Clin Intern Med，2015，32（12）：831-833.
29. 29.
    JIANG M，ZHANG W T，SU X，et al.Identifying and measuring the severity of somatic symptom disorder using the Self-reported Somatic Symptom Scale-China （SSS-CN）：A research protocol for a diagnostic study［J］.BMJ Open，2019，9（9）：e024290.
30. 30.
    Branch of Cardiovascular Physicians of Chinese Medical Doctor Association，Psycho-cardiology Group of Beijing Medical Association .Expert consensus on diagnosis and treatment of stable coronary artery disease combined with mental disorders in primary care （2023 edition）［J］.Chin J Gen Pract，2023，22（12）：1224-1234.
31. 31.
    LI J M.Introduction to the sleep status self-rating scale （SRSS）［J］.CJHP，2012，20（12）：1851.
32. 32.
    BRINZA C，FLORIA M，SCRIPCARIU D V，et al.Heart rate variability in acute myocardial infarction：Results of the HeaRt-V-AMI single-center cohort study［J］.J Cardiovasc Dev Dis，2024，11（8）：254.
33. 33.
    ANH HOANG T A，TRAN N L，NGUYEN N T，et al.Prognosis value of heart rate variability measured by Camera HRV application in patients after acute myocardial infarction［J］.Indian Heart J，2024，76（4）：306-308.
34. 34.
    LEE D，KIM S J，CHEON J，et al.Changes in interoceptive accuracy related to emotional interference in somatic symptom disorder［J］.BMC Psychol，2024，12（1）：279.
35. 35.
    KLEBER F，REIF A，DE GRECK M.The effect of social exclusion on pain perception and heart rate variability in healthy controls and somatoform pain patients［J］.Scand J Pain，2024，24（1）：20240042.
36. 36.
    FANG S C，WU Y L，TSAI P S.Heart rate variability and risk of all-cause death and cardiovascular events in patients with cardiovascular disease：A Meta-analysis of cohort studies［J］.Biol Res Nurs，2020，22（1）：45-56.